Lipid-rich plaque inhibitors
AssigneeTakeda Pharmaceutical Company Limited
InventorsZen-ichi Terashita, Masahira Nakamura, Shogo Marui, Masaki Ogino
Life of this patent
Estimating the term…
Loading patent…
AssigneeTakeda Pharmaceutical Company Limited
InventorsZen-ichi Terashita, Masahira Nakamura, Shogo Marui, Masaki Ogino
Estimating the term…
The present invention provides a lipid-rich plaque regressing agent comprising a compound represented by Formula: 1 in which ring A is a cyclic hydrocarbon or the like; ring B is a heterocyclic ring or the like; each of X and Y is —NR1— (in which R1 is a hydrocarbon or the like); D is a C1-3 alkylene group or the like; E is —NH— or the like; G is a bond or the like; and Ar is an aryl or the like; D may be taken together with a constituent atom of the ring B to form a ring, and R4 may be taken together with a constituent atom of the ring B to form a ring.
A lipid-rich plaque regressing agent comprising a compound represented by Formula [I]:
A compound represented by Formula [V]:
A compound represented by Formula [VI]:
2-[7-Chloro-4-(3-chlorophenyl)-6-methyl-2-oxo-2H-chromen-3-yl]-N-[4-chloro-2-(trifluoromethyl)phenyl]acetamide;
An agent for inhibiting progression of an arteriosclerotic focus comprising a compound having a lipid-rich plaque regressing effect or a salt thereof.
Dependencies are inferred from the claim text.